Thrivent Financial for Lutherans’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
Thrivent Financial for Lutherans's IHE Position: Q3 2025 in Review
Thrivent Financial for Lutherans sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2025, closing a stake of 37,636 shares — an estimated $2.47M sold.
Thrivent Financial for Lutherans first reported a position in IHE in Q1 2022 and held it in 14 quarters. The position peaked at $2.54M in Q1 2025. 150 funds tracked by Wall St. Rank hold IHE as of Q3 2025.
- Thrivent Financial for Lutherans reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2025 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 37,636 iShares US Pharmaceuticals ETF shares in Q3 2025, an estimated $2.47M.
- Thrivent Financial for Lutherans first reported a position in iShares US Pharmaceuticals ETF in Q1 2022 and held it in 14 quarters.
- Thrivent Financial for Lutherans's iShares US Pharmaceuticals ETF position peaked at $2.54M in Q1 2025.
- 150 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2025.
Based on Thrivent Financial for Lutherans's 13F filing for Q3 2025, filed 4 Nov 2025.